How Low Is "Low T"? The Number You Think You Know vs. the Number That Matters

Your testosterone came back at 380. One clinic tells you that’s fine. Another tells you you’re a candidate for TRT. A third quotes 800 as the floor of “optimal.” All three are reading the same number on the same lab report.

The threshold for low testosterone is more contested than most patients realize. The specialty societies broadly agree on a diagnostic cutoff, but they also agree it’s the start of the workup, not the end of it. The clinics chasing “optimization” use a different yardstick entirely, and it’s worth knowing which conversation you’re in before starting a therapy that suppresses your own production.

Here is the version we give our own patients.

The American Urological Association’s Evaluation and Management of Testosterone Deficiency guideline — the most-cited reference in U.S. urology practice — defines testosterone deficiency as a total testosterone of less than 300 ng/dL on two separate early-morning measurements, combined with symptoms or signs. Both pieces are required.

The Endocrine Society’s clinical practice guideline cites the harmonized reference range derived from the CDC’s standardization program: in healthy non-obese young men aged 19–39, the 2.5th–97.5th percentile range is 264 to 916 ng/dL. The Endocrine Society requires that the diagnosis only be made when low levels are “unequivocally and consistently” paired with symptoms.

The bottom of “normal” lives somewhere between 264 and 300 ng/dL depending on which guideline you’re reading. That gap matters less than people think — both sets of authors point at the same idea: symptoms, a low number, and a confirmation draw before you call it hypogonadism.

Testosterone is one of the most circadian hormones in the body. It peaks in the early morning, typically between 7 and 10 a.m., and falls by 20–25% across the day in younger men. An afternoon level will almost always read lower than a morning level on the same patient.

Day-to-day biology adds another layer. Acute illness, a poor night of sleep, a hard workout, or a stressful week can all swing testosterone meaningfully. Studies of repeated sampling show that roughly a third of men with one low reading have a normal level on a repeat draw — which is why every major guideline insists on confirmation.

The strongest argument for two morning draws is that the alternative turns a normal fluctuation into a lifetime of injections. That is the failure mode of single-lab telehealth: the test is timed for convenience, symptoms are checked off a form, the prescription is issued, and a man who never had hypogonadism is now on therapy that suppresses his own production.

Total testosterone is one number on a sheet that should have several. Each of the others tells you something total T can’t, and any of them can be the reason a “borderline low” man is actually fine — or a “normal” man is actually symptomatic.

Free testosterone is the small fraction — roughly 1–2% in most men — that isn’t bound to SHBG or albumin and is therefore available to tissues. When SHBG is high, total T can look normal while free T is genuinely low. When SHBG is low, total T can look low while free T is fine.

SHBG (sex hormone-binding globulin) is the carrier protein that holds most circulating testosterone. It rises with aging, hyperthyroidism, and liver disease, and falls with obesity, type 2 diabetes, and insulin resistance. SHBG is the reason total and free testosterone don’t track each other one-for-one — and it’s the most common reason a total T number is misleading.

LH and FSH are the pituitary signals that tell the testes to make testosterone and sperm. They distinguish primary hypogonadism (testes failing, LH/FSH high) from secondary hypogonadism (pituitary or hypothalamus failing, LH/FSH low or inappropriately normal). That distinction may point to a pituitary issue, recent opioid use, or anabolic steroid history that warrants its own workup before testosterone is prescribed.

Estradiol, prolactin, hematocrit, PSA, and a metabolic panel round out a baseline — some for diagnosis, some for safety and candidacy.

On free T measurement: the Endocrine Society treats equilibrium dialysis as the gold standard but accepts a calculated free testosterone (from total T, SHBG, and albumin) as a reasonable alternative. The cheaper “direct” immunoassay free T offered by some labs is widely considered unreliable and is not what guidelines recommend.

Some clinics — especially cash-pay, marketing-forward telehealth shops — talk about a target range of 800 to 1,100 ng/dL as where men should “feel their best.” That sits in the upper end of the normal reference but is well above where most untreated men actually live, and the evidence that putting them there improves long-term outcomes is thin.

Targeting the top of the reference range is a values choice, not a diagnostic threshold. The guidelines diagnose hypogonadism around 264–300 ng/dL because that is where the population data and the symptom association live. No major society guideline endorses “optimization” to 800–1,100 as standard practice. When a clinic frames that range as the medical goal, they are blending a marketing pitch with a clinical-sounding number. The side-effect profile of TRT — polycythemia, fertility suppression, the small arrhythmia signal seen in TRAVERSE — does not get better at higher levels. If anything, it gets worse.

The guidelines agree on something the optimization clinics tend to skip: reversible causes should be identified and addressed before testosterone is prescribed. Many men who walk in with a borderline-low number are dealing with one or more of these:

• Obesity. Adipose tissue converts testosterone to estradiol and lowers SHBG. Weight loss reliably raises total testosterone in men with obesity — sometimes enough to move them out of the “low” range entirely.
• Untreated obstructive sleep apnea. OSA suppresses testosterone via disrupted sleep architecture; treating it can raise levels meaningfully.
• Acute illness or recent surgery. A bad flu or a recent procedure can drop testosterone temporarily; labs during that window misclassify the baseline.
• Opioids and chronic glucocorticoids. Both suppress the HPG axis, often dramatically.
• Heavy cannabis use. Chronic use has been associated with lower testosterone in multiple cohort studies; effects vary.
• Chronic stress and severe sleep restriction. Both shift HPA-axis activity in ways that lower testosterone in some men.

None of this means a man with low T and one of these factors isn’t a TRT candidate. It means the workup should look at the whole picture first — because some of these are fixable, and starting exogenous testosterone before they’re addressed locks in a problem that didn’t need to be locked in.

A methodical workup looks roughly like this: two morning total testosterone draws on separate days (both before 10 a.m.); a full panel that includes SHBG, free testosterone (calculated from CDC-certified total T or measured by equilibrium dialysis), LH, FSH, estradiol, prolactin, hematocrit, PSA where appropriate, and basic metabolic and lipid panels; a history that screens for reversible causes; and a clinical conversation that ties the labs to the symptoms before anything is prescribed.

That isn’t what a $99 telehealth intake delivers — but it isn’t exotic either. It is the standard the AUA and Endocrine Society have written down.

If your number came back borderline, or if you’ve been told you need TRT after a single lab, that’s exactly the kind of conversation we have at Naya Wellness. Carolyn Pampalone, MSN, FNP-BC, has nearly two decades in hormone care and can walk you through what your panel means, what’s worth a confirmation draw, and what — if anything — should be addressed before testosterone enters the picture. You can talk it through at our Chatsworth or Santa Barbara clinics, or by telehealth across California.

Two California locations and statewide telehealth — click a card to view details, or call to schedule a consult.